OUR GENESIS
Next-Generation 3D In Vitro Models of Human Disease with Bioengineering Tools
Cellularis Biomodels leverages on advanced bioengineering technologies to research and produce physiomimetic human-based 3D disease models in vitro with a focus in screening candidate therapies in the pre-clinical phase.
OUR PIPELINE
Breakthrough Bioengineered Technologies to Reshape Personalize Medicine
Our proprietary bioengineering technologies enable the production of physiomimetic 3D disease models that recapitulate key tumor-stroma hallmarks, bioarchitecture and anatomic scale in an in vitro setting.
DESIGN PHASE
BIOENGINEERING PHASE
VALIDATION PHASE
Physiomimetic 3D model comprising tumor-stroma lung-specific decellularized matrix
Physiomimetic 3D model comprising tumor-stroma pancreatic-specific decellularized matrix
Physiomimetic 3D model comprising tumor-stroma breast-specific decellularized matrix
Physiomimetic 3D model comprising tumor-stroma prostate-specific decellularized matrix
Physiomimetic 3D model comprising tumor-stroma glioblastoma-specific decellularized matrix
Explore our Technologies
Tumors in Microparticles
3D Tumor-ECM Spheroids
Tumor in Micro/Macrogels
Anatomic-Scale Tumor Models
OUR SERVICES
Find our latest news and events
Cellularis on the air
CEO | Vitor Gaspar
“Our technology allows us to use human cells and process human tissue to create mini tumors that can be mimetic of human disease.”
World patent
Pancreatic Tumor-Stroma Models
Cellularis files its first international patent request focusing on the bioengineering of physiomimetic 3D in vitro tumor models recapitulating cancer-stroma interactions.
BIO´n´TEQ
Biocant Park | Cantanhede
Cellularis was present at BIO’n’TEQ, a biotechnology technological exhibition organized by Biocant and AEMITEQ under INOVC+ Project.
Meet Us
Creative Science Park Aveiro
Call Us
+351 234 243 750
Email Us
cellularis.biomodels@outlook.com info@cellularisbiomodels.com